Abstract：
BACKGROUND:The epithelial cell adhesion molecule (EpCAM) has been shown to be overexpressed in breast cancer and stem cells and has emerged as an attractive target for immunotherapy of breast cancer patients. This study analyzes the effects of EpCAM on breast cancer cell lines with epithelial or mesenchymal phenotype. METHODS:For this purpose, shRNA-mediated knockdown of EpCAM gene expression was performed in EpCAMhigh breast cancer cell lines with epithelial phenotype (MCF-7, T47D and SkBR3). Moreover, EpCAMlow breast carcinoma cell lines with mesenchymal phenotype (MDA-MB-231, Hs578t) and inducible overexpression of EpCAM were used to study effects on proliferation, migration and in vivo growth. RESULTS:In comparison to non-specific silencing controls (n/s-crtl) knockdown of EpCAM (E#2) in EpCAMhigh cell lines resulted in reduced cell proliferation under serum-reduced culture conditions. Moreover, DNA synthesis under 3D culture conditions in collagen was significantly reduced. Xenografts of MCF-7 and T47D cells with knockdown of EpCAM formed smaller tumors that were less invasive. EpCAMlow cell lines with tetracycline-inducible overexpression of EpCAM showed no increased cell proliferation or migration under serum-reduced growth conditions. MDA-MB-231 xenografts with EpCAM overexpression showed reduced invasion into host tissue and more infiltrates of chicken granulocytes. CONCLUSIONS:The role of EpCAM in breast cancer strongly depends on the epithelial or mesenchymal phenotype of tumor cells. Cancer cells with epithelial phenotype need EpCAM as a growth- and invasion-promoting factor, whereas tumor cells with a mesenchymal phenotype are independent of EpCAM in invasion processes and tumor progression. These findings might have clinical implications for EpCAM-based targeting strategies in patients with invasive breast cancer.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Martowicz A,Spizzo G,Gastl G,Untergasser Gdoi
10.1186/1471-2407-12-501subject
Has Abstractpub_date
2012-10-30 00:00:00pages
501issn
1471-2407pii
1471-2407-12-501journal_volume
12pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:Triple-negative breast cancer (TNBC) is a type of breast cancer with a high degree of malignancy. Because of the remarkable biological characteristics of high invasion, metastasis and recurrence, TNBC is often accompanied by a poor prognosis. As a molecular characteristic of TNBC, high expression of CD147 ha...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5796-9
更新日期：2019-06-13 00:00:00
abstract：BACKGROUND:In this era of oxaliplatin-based adjuvant therapy, the optimal sequence in which chemoradiotherapy should be administered for pathological stage N2 rectal cancer is unknown. The aim of this study was to investigate this sequence. METHODS:In the primary adjuvant concurrent chemoradiotherapy (A-CRT) group (n ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3170-3
更新日期：2017-03-09 00:00:00
abstract：BACKGROUND:Human studies of dietary fat as a possible risk factor for cutaneous malignant melanoma (CMM) and non-melanoma skin cancer (NMSC)--principally basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)--have produced inconsistent results. We had the opportunity to examine the association concurrently for a...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-6-141
更新日期：2006-05-30 00:00:00
abstract：BACKGROUND:The facts that LPA is present at high concentration in ovarian cancer patients' ascites and it may serve as a stimulator to cell migration, implicate the role of LPA in the ovarian cancer metastasis. Since LPA mediates various biological functions through its interaction with LPA receptors, we aim to investi...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2865-1
更新日期：2016-11-04 00:00:00
abstract：BACKGROUND:Several lines of evidence indicate that Sirt1, a class III histone deacetylase (HDAC) is implicated in the initiation and progression of malignancies and thus gained attraction as druggable target. Since data on the role of Sirt1 in pancreatic ductal adenocarcinoma (PDAC) are sparse, we investigated the expr...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-450
更新日期：2013-10-02 00:00:00
abstract：BACKGROUND:Interleukin 12 (IL-12) is a cytokine that has been reported to exhibit potent tumoricidal effects in animal tumor models. A combined approach using Paclitaxel and platinum-based doublet chemotherapy is the most commonly used backbone regimen for treating lung cancer. Despite numerous studies regarding the an...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2701-7
更新日期：2016-08-22 00:00:00
abstract：BACKGROUND:Alterations in peripheral blood lymphocytes in cervical cancer have been reported, although conflicting views exist. The present study investigated the distributions of lymphocyte subsets in tumor tissue and peripheral blood samples from cervical cancer patients and precancerous lesion patients, and evaluate...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-6633-x
更新日期：2020-03-04 00:00:00
abstract：BACKGROUND:Uridine 5'-diphosphate-glucuronosyltransferase 2B (UGT2B) genes code for enzymes that catalyze the clearance of testosterone, dihydrotestosterone (DHT), and DHT metabolites in the prostate basal and luminal tissue. The expression of the UGT2B15, UGT2B17, and UGT2B28 enzymes has not been evaluated in prostate...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3463-6
更新日期：2017-07-03 00:00:00
abstract：BACKGROUND:Genomic initiatives such as The Cancer Genome Atlas (TCGA) contain data from -omics profiling of thousands of tumor samples, which may be used to decipher cancer signaling, and related alterations. Managing and analyzing data from large-scale projects, such as TCGA, is a demanding task. It is difficult to di...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5965-x
更新日期：2019-08-20 00:00:00
abstract：BACKGROUND:The aim of this study was to determine whether early tumor shrinkage (ETS) at 6 weeks after treatment correlates with progression-free survival (PFS) and overall survival (OS) in advanced biliary tract cancer (BTC) patients receiving gemcitabine plus oxaliplatin (GEMOX), with or without erlotinib. METHODS:T...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.1186/s12885-015-1552-y
更新日期：2015-07-21 00:00:00
abstract：BACKGROUND:Cancer cell repopulation during chemotherapy or radiotherapy is a major factor limiting the efficacy of treatment. Cancer stem cells (CSC) may play critical roles during this process. We aim to demonstrate the role of mesothelioma stem cells (MSC) in treatment failure and eventually to design specific target...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4354-1
更新日期：2018-04-27 00:00:00
abstract：BACKGROUND:We evaluated possible diagnostic and prognostic values of serum midkine in malignant pleural mesothelioma in comparison with those of serum mesothelin, a well-established diagnostic biomarker. METHODS:Serum mesothelin and midkine levels were determined with an enzyme-linked immunosorbent assay. We examined ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3209-5
更新日期：2017-03-23 00:00:00
abstract：BACKGROUND:Renal cell carcinoma (RCC) is a malignant disease that demonstrates resistance to standard chemotherapeutic agents. Yet Active immunization using genetically modified dendritic cells holds promise for the adjuvant treatment of malignancies to eradicate or control residual disease. Cytokine-induced killer (CI...
journal_title：BMC cancer
pub_type： 临床试验,杂志文章
doi：10.1186/1471-2407-14-251
更新日期：2014-04-10 00:00:00
abstract：BACKGROUND:To date, the clinical benefit of topical steroid use has only been demonstrated for radiation dermatitis induced by 50-60 Gy irradiation in breast cancer. However, these agents are also often used clinically for the control of radiation dermatitis induced by high-dose (>60Gy) irradiation with chemotherapy in...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4763-1
更新日期：2018-09-06 00:00:00
abstract：BACKGROUND:Recently, a phase II clinical trial in hepatocellular carcinoma (HCC) has suggested that the combination of sorafenib and 5-fluorouracil (5-FU) is feasible and side effects are manageable. However, preclinical experimental data explaining the interaction mechanism(s) are lacking. Our objective is to investig...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-363
更新日期：2013-07-29 00:00:00
abstract：BACKGROUND:The role of occupation in the etiology of renal cell carcinoma (RCC) is unclear. Here, we investigated associations between employment in specific occupations and industries and RCC, and its most common histologic subtype, clear cell RCC (ccRCC). METHODS:Between 2002 and 2007, a population-based case-contro...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-344
更新日期：2012-08-08 00:00:00
abstract：BACKGROUND:There is international interest in risk-stratification of breast screening programmes to allow women at higher risk to benefit from more frequent screening and chemoprevention. Risk-stratification also identifies women at low-risk who could be screened less frequently, as the harms of breast screening may ou...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07158-9
更新日期：2020-07-22 00:00:00
abstract：BACKGROUND:TGFβ signaling has typically been associated with suppression of tumor initiation while the role it plays in metastasis is generally associated with progression of malignancy. However, we present evidence here for an anti-metastatic role of TGFβ signaling. METHODS:To test the importance of TGFβ signaling to...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-221
更新日期：2012-06-06 00:00:00
abstract：BACKGROUND:The sex hormone-binding globulin (SHBG) is a carrier protein that modulates the bio-availability of serum sex steroid hormones, which may be involved in ovarian cancer. We evaluated whether common genetic variation in SHBG and its 3' neighbor ATP1B2, in linkage disequilibrium, is associated with the risk of ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-7-60
更新日期：2007-04-05 00:00:00
abstract：BACKGROUND:The incidence of Cholangiocellular Carcinoma (CCA) is increasing in the western world. The tumour has a high proportion of desmoplastic stroma and is correlated with a worse prognosis when cancer associated myofibroblasts (CAFs) are present. Recent studies showed promising results after liver transplantation...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2360-8
更新日期：2016-05-20 00:00:00
abstract：BACKGROUND:Epidemiological studies show that cigarette smoking increase the risk of nasopharyngeal carcinoma (NPC), however, whether other common, potentially adverse household inhalants increase NPC risk remains uncertain. METHODS:We conducted a large case-control study to explore the effects of household inhalants, ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-2035-x
更新日期：2015-12-29 00:00:00
abstract：BACKGROUND:Response-guided neoadjuvant chemotherapy (RG-NACT) with magnetic resonance imaging (MRI) is effective in treating oestrogen receptor positive/human epidermal growth factor receptor-2 negative (ER-positive/HER2-negative) breast cancer. We estimated the expected cost-effectiveness and resources required for it...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2653-y
更新日期：2016-09-05 00:00:00
abstract：BACKGROUNDS:Cancer stem cell (CSC) research has highlighted the necessity of developing drugs targeting CSCs. We investigated a hepatocellular carcinoma (HCC) cell line that not only has CSC hierarchy but also shows phenotypic changes (population changes) upon differentiation of CSC during culture and can be used for s...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1297-7
更新日期：2015-04-11 00:00:00
abstract：BACKGROUND:Pancreatic adenocarcinoma is one of the most dreaded cancers with very low survival rate and poor prognosis to the existing frontline chemotherapeutic drugs. Gene therapy in combination with a cytotoxic agent could be a promising approach to circumvent the limitations of previously attempted therapeutic inte...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-75
更新日期：2014-02-08 00:00:00
abstract：BACKGROUND:HOXA family genes were crucial transcription factors involving cell proliferation and apoptosis. While few studies have focused on HOXA10 in AML. We aimed to investigate the prognostic significance of HOXA10. METHODS:We downloaded datasets from GEO and BeatAML database, to compare HOXA expression level betw...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07088-6
更新日期：2020-06-22 00:00:00
abstract：BACKGROUND:Double stranded RNA (dsRNA) has multiple anti-tumor mechanisms. Over the past several decades, there have been numerous attempts to utilize synthetic dsRNA to control tumor growth in animal models and clinical trials. Recently, it became clear that intracellular dsRNA is more effective than extracellular dsR...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-110
更新日期：2011-03-28 00:00:00
abstract：BACKGROUND:Reactivation of hepatitis B or C virus can occur in patients undergoing chemotherapy. Recommendations for selective or systematic hepatitis B virus testing prior chemotherapy for solid tumors differ. The primary aim was to determine the seroprevalence of hepatitis B or C in a low endemic country. The second ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-2033-z
更新日期：2015-12-23 00:00:00
abstract：BACKGROUND:To evaluate the safety and efficacy of intra-arterial chemotherapy (IAC) for the primary or secondary treatment of infants diagnosed with advanced retinoblastoma before 3 months of age. METHODS:This single-center retrospective study included 39 infants (42 eyes) aged ≤3 months who were diagnosed with unilat...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5844-5
更新日期：2019-07-15 00:00:00
abstract：BACKGROUND:Metastatic breast cancer (MBC) rest an incurably disease associated with bad prognosis and a median overall survival of 23-31 months. There are several treatment options including chemotherapy and sometimes endocrine therapy. Currently, there is no standard treatment for patients with MBC who have already be...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4725-7
更新日期：2018-08-20 00:00:00
abstract：BACKGROUND:Ovarian cancer is the leading cause of death among gynecologic diseases in Western countries. We have previously identified a miR-200-E-cadherin axis that plays an important role in ovarian inclusion cyst formation and tumor invasion. The purpose of this study was to determine if the miR-200 pathway is invol...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3417-z
更新日期：2017-06-17 00:00:00
